People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nanosys, Inc. | — | Other Technology | Series B | $96.9M | $296.6M | 2022 |
Wes Goldstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wes Goldstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Keith Crandell | 1 | 11 |
| John Young | 1 | 7 |
| Nelson Chan | 1 | 7 |
| Regis McKenna | 1 | 3 |
| Bruce Berkoff | 1 | 3 |
| Young Sohn | 1 | 3 |
| Stephen Oesterle | 1 | 3 |
| Steven Goldby | 1 | 3 |
| Jim McCanna | 1 | 2 |
| Homer Antoniadis | 1 | 2 |
| Martin Devenney | 1 | 1 |
| Joun Ho Lee | 1 | 1 |
| Eugene Hong | 1 | 1 |
| Dr. Yijie Huo | 1 | 1 |
| Gregory Yurek | 1 | 1 |
| Jason Hartlove | 1 | 1 |
| John Page | 1 | 1 |
| Greg Yurek | 1 | 1 |
| Stephen Oesterle, M.D. | 1 | 1 |
| Jian Chen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.